GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory. [electronic resource]
Producer: 20180425Description: 47 p. digitalISSN:- 2051-1426
- Animals
- Antigens, Neoplasm -- immunology
- CD8-Positive T-Lymphocytes -- drug effects
- Cancer Vaccines -- administration & dosage
- Colonic Neoplasms -- drug therapy
- Disease Models, Animal
- Female
- Glucocorticoid-Induced TNFR-Related Protein -- agonists
- Humans
- Mice
- Oncogene Proteins, Fusion -- antagonists & inhibitors
- Receptors, Tumor Necrosis Factor -- genetics
- Signal Transduction -- drug effects
- T-Lymphocytes, Regulatory -- drug effects
- Tumor Necrosis Factors -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.